IP Library Granted Patent US 8,664,267
Granted Patent B2
US 8,664,267 · App. 11/786,351 · Granted Mar 4, 2014

Parenteral solution containing amiodarone in NNDMA (N,N,-Dimethylacetamide)

Inventors: John Charin Somberg (Lake Forest, IL); Vasant V. Ranade (Libertyville, IL)
Assignee: Academic Pharmaceuticals Incorporated
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,664,267
App. No.
11/786,351
Granted
Mar 4, 2014
Kind
B2
Abstract

Disclosed herein are parenteral solutions containing 3-diethylaminoethoxy benzoyl-benzofurans, such as amiodarone, in a diluent NNDMA (N,N-Dimethylacetamide) useful in the treatment of cardiac arrhythmias both supraventricular, ventricular as well as, the condition of cardiac arrest.

Claims (18)

1. A solution suitable for parenteral administration which comprises as an active ingredient about 10 to 100 mg/mL of amiodarone, about 1-50% by volume in NNDMA (N,N-dimethylacetamide), and the remainder being 5% dextrose solution.

2. The solution of claim 1 , wherein the solution has a pH of 4.5 to 7.0.

3. The solution of claim 2 , wherein the pH is from 6.0 to 6.5.

4. The solution of claim 2 , wherein the pH is from 4.5 to 6.5.

5. The solution of claim 1 , wherein 20 mg/mL of amiodarone is present.

6. The solution of claim 1 , wherein 10-100 mg/mL of amiodarone is present in about 1% by volume in NNDMA and the remainder being 5% dextrose solution.

7. The solution of claim 6 , wherein the pH is from 4.5 to 6.5.

8. The solution of claim 7 , wherein the pH is from 6.0 to 6.5.

9. The solution of claim 1 , wherein 10-20 mg/mL of amiodarone is present.

10. The solution of claim 1 , wherein 10-20 mg/mL of amiodarone is present in about 1% by volume in NNDMA and the remainder being 5% dextrose solution.

11. The solution of claim 10 , wherein the pH is from 4.5 to 6.5.

12. The solution of claim 11 , wherein the pH is from 6.0 to 6.5.

13. The solution of claim 1 , wherein 2% by volume of NNDMA is present.

14. The solution of claim 13 , wherein the pH is from 4.5 to 6.5.

15. The solution of claim 13 , wherein the pH is from 6.0 to 6.5.

16. The solution of claim 1 , wherein 10-20 mg/mL of amiodarone is present in about 2% by volume in NNDMA and the remainder being 5% dextrose solution.

17. The solution of claim 16 , wherein the pH is from 4.5 to 6.5.

18. The solution of claim 17 , wherein the pH is from 6.0 to 6.5.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 24, 2010
From: JOHN C SOMBERG; VASANT V RANADE
To: ACADEMIC PHARMACEUTICALS INCORPORATED
Reel/Frame 025420/0064 →
Continuity (1)
Related Publication 20080255229A1 · Oct 16, 2008